| PERIOD ENDING | 30-Nov-09 | 31-Aug-09 | 31-May-09 | 28-Feb-09 | | Total Revenue | 1,270,301 | 1,075,763 | 1,051,343 | 876,129 | | Cost of Revenue | 529,496 | 452,913 | 400,202 | 373,290 | | | Gross Profit | 740,805 | 622,850 | 651,141 | 502,839 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 347,910 | 351,773 | 315,151 | 296,811 | | Non Recurring |
-
| 80,500 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 392,895 | 190,577 | 335,990 | 206,028 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 66 | (4,843) | 6,165 | 1,977 | | Earnings Before Interest And Taxes | 392,961 | 185,734 | 342,155 | 208,005 | | Interest Expense | 2,911 | 1,960 | 2,500 |
-
| | Income Before Tax | 390,050 | 183,774 | 339,655 | 208,005 | | Income Tax Expense | 149,918 | 95,940 | 139,043 | 82,929 | | Minority Interest | 10 | 3,675 | 492 | 270 | | | | Net Income From Continuing Ops | 240,142 | 91,509 | 201,104 | 125,346 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 240,142 | 91,509 | 201,104 | 125,346 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $240,142 | $91,509 | $201,104 | $125,346 |
|
0.31% Nasdaq 
Income Statement
